Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miner who wrote (8332)	1/3/2002 2:08:10 PM
From: Mark Bartlett	Read Replies (2) of 14101

Miner, <<but are any of the fellowship descriptions indirectly indicating a line of study that might incorporate WF10 at some point?>> Possibly. The areas of study describes are very broad -- I do not understand them all either. My sense is that assuming WF10 is approved, it will likely see initial off label use in those cases of cancer that are particularly refractory and where there are no other options. This would be in addition to its use for approved HIV treatment. There are many possible uses for WF10 -- many where there is already anecdotal evidence of benefit. IMO they should focus new research on asthma and autoimmune diseases like Crohn's disease, lupus, MS and psoriasis. They are all very serious conditions with huge market potential. MB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next